COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience.
Aspergillus
CAPA
COVID-19
Galactomannan
Isavuconazole
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
30 Jan 2024
30 Jan 2024
Historique:
received:
11
05
2023
revised:
30
12
2023
accepted:
05
01
2024
medline:
31
1
2024
pubmed:
31
1
2024
entrez:
31
1
2024
Statut:
epublish
Résumé
Since 2020, cases of COVID-19-associated pulmonary aspergillosis (CAPA) have been frequently described, representing an important cause of mortality, especially among patients admitted to intensive care unit (ICU). A predisposition to invasive infection caused by
Identifiants
pubmed: 38293516
doi: 10.1016/j.heliyon.2024.e24298
pii: S2405-8440(24)00329-3
pmc: PMC10825494
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e24298Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.